Identifying and Investing in the Next Generation of Biotech, AI, Robotics, Quantum, and Defence Innovators
A bridge between breakthrough innovation & public-market participation
FutureGen provides early access to high-potential technology investment opportunities and works closely with founders to develop, commercialize, and scale breakthrough innovations. We combine capital, scientific insight, and strategic execution support at the earliest stages, and maintain an ETF-style public-markets strategy that offers exposure to sector-leading companies alongside emerging innovators.
Global Innovation Market Landscape
Large-scale opportunity across foundational technology sectors.
Biotech
The global biotechnology market is estimated at ~USD 1.77T in 2025 and forecast to reach ~USD 5.71T by 2034, growing at a ~13.9% CAGR1. Growth is fueled by advances in biologics, cell and gene therapies, synthetic biology, and AI-enabled drug discovery and bio-manufacturing
Artificial Intelligence
The global artificial intelligence market is estimated at ~USD 638B in 2025, growing to ~USD 3.68T by 2034 at a ~19.2% CAGR2. Adoption is accelerating through enterprise deployment of foundation and generative models, automation across industries, and expanding compute and data infrastructure
Defence Technologies
A global market valued at approximately USD 541 billion in 2025 and projected to approach USD 985 billion by 20343. Expansion is driven by modernization programs, increased adoption of AI-enabled systems, cyber warfare capabilities, unmanned and autonomous systems, next-generation platforms, and space-based defence assets.
Robotics
The global robotics market is estimated at ~USD 53B in 2024, projected to reach ~USD 179B by 2033 at a ~16.3% CAGR4. Growth is driven by advances in AI-powered autonomy, industrial automation, healthcare robotics, & sensing systems.
Quantum Technologies
The global quantum computing market is estimated at ~USD 1.7B in 2025, expected to exceed ~USD 4B by 2030 at a ~20.5% CAGR5. Early adoption is emerging across simulation, optimization, cybersecurity & advanced computing applications.
What Sets Us Apart
Our Differentiators and Value add to Founders / Portfolio Companies.
Deep Scientific and Technical Insight
A foundation built on scientific excellence and real-world innovation, enabling disciplined evaluation and support of emerging technologies. Our leadership has built and scaled companies from lab to commercialization and public-market environments.
Early-Stage Access and Support
Access to promising early-stage opportunities with hands-on commercialization guidance, operational support, and strategic execution resources. We work closely with companies to support responsible development, scale, and long-term success.
Strategic Academic and Industry Networks
Trusted access to leading research institutions and innovation hubs, including Stanford, McMaster, University of British Columbia, and Silicon Valley ecosystems, providing early insight into emerging technologies, breakthroughs, and talent.
ETF-Style Public-Markets Strategy
ETF-style exposure to sector-leading public technology companies, complementing early-stage investments with diversified access to innovation.
